These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 5081011)
1. The development of plasma derivatives in Switzerland. Kistler P Vox Sang; 1972; 23(1):26-31. PubMed ID: 5081011 [No Abstract] [Full Text] [Related]
2. Experiences in the development of plasma derivatives in Japan. Naito R Vox Sang; 1972; 23(1):35-7. PubMed ID: 4117047 [No Abstract] [Full Text] [Related]
3. The current status of blood fractionation in the United States. Sgouris JT Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014 [No Abstract] [Full Text] [Related]
4. The development of plasma derivatives in Canada. McVicar GA Vox Sang; 1972; 23(1):33-4. PubMed ID: 4117046 [No Abstract] [Full Text] [Related]
5. Plasma fractionation in England and Wales. Vallet L Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157 [No Abstract] [Full Text] [Related]
6. The development of plasma derivatives for clinical use. A symposium summary. Deutsch HF Vox Sang; 1972; 23(1):147-50. PubMed ID: 5081010 [No Abstract] [Full Text] [Related]
7. Notes on the development of plasma derivatives in the Netherlands. Krijnen HW Vox Sang; 1972; 23(1):32. PubMed ID: 5081012 [No Abstract] [Full Text] [Related]
8. Round table discussion on regulatory and other problems, including hepatitis, in the development of plasma derivatives. Vox Sang; 1972; 23(1):72-9. PubMed ID: 5081017 [No Abstract] [Full Text] [Related]
9. Notes on plasma derivative production in the Federal Republic of Germany. Schwick HG Vox Sang; 1972; 23(1):44. PubMed ID: 5081013 [No Abstract] [Full Text] [Related]
10. Development of plasma derivatives for clinical use. Tullis JL Vox Sang; 1972; 23(1):3-9. PubMed ID: 4117048 [No Abstract] [Full Text] [Related]
11. [Plasmapheresis in normal donors ]. Frey-Wettstein M Ther Umsch; 1982 Jul; 39(7):551-4. PubMed ID: 7123508 [No Abstract] [Full Text] [Related]
13. The development of plasma derivatives in Australia. Schiff P Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156 [No Abstract] [Full Text] [Related]
14. [Blood transfusion 1975]. Hässig A Z Krankenpfl; 1975 Nov; 68(11):312-6. PubMed ID: 1043566 [No Abstract] [Full Text] [Related]
15. [50 years of blood transfusion services of the Swiss Red Cross]. Hässig A Schweiz Med Wochenschr; 1991 Feb; 121(5):156-9. PubMed ID: 2003212 [TBL] [Abstract][Full Text] [Related]
16. Can a national all voluntary blood transfusion service by adequate blood component therapy cover actual and future needs of albumin? Barker LF; Cazal P; Haussman HG; Hollán S; Kellner A; Lundsgaard-Hansen P; Schiff P Vox Sang; 1976; 31?-73(3):225-38. PubMed ID: 969394 [No Abstract] [Full Text] [Related]
17. Plasma fractionation in the United States. A review for clinicians. Ness PM; Pennington RM JAMA; 1974 Oct; 230(2):247-50. PubMed ID: 4137885 [No Abstract] [Full Text] [Related]
18. Fractionation of plasma with polyethylene glycol. Polson A; Ruiz-Bravo C Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005 [No Abstract] [Full Text] [Related]
19. The provision of plasma for the derivatives program of the Swiss Red Cross blood transfusion service. Hässig A Haematologia (Budap); 1980; 13(1-4):169-73. PubMed ID: 7250810 [No Abstract] [Full Text] [Related]
20. [Transfusion medicine and blood donor services. The organization of the Blood Donor Service of the Swiss Red Cross]. Bucher H Ther Umsch; 1984 Aug; 41(8):536-9. PubMed ID: 6495229 [No Abstract] [Full Text] [Related] [Next] [New Search]